Overview

Drug Use Investigation On Zithromac (Azithromycin) In HIV Patients

Status:
Completed
Trial end date:
2012-03-01
Target enrollment:
Participant gender:
Summary
The investigation will be conducted for the purpose of determining the condition of occurrence of Adverse Events under the actual post-marketing use of Zithromac 600mg Tablet, verifying the therapeutic effects, detecting unknown Adverse Drug Reactions and drug interactions and determining the factors affecting safety and efficacy.
Details
Lead Sponsor:
Pfizer
Collaborator:
Altmarc Inc.
Treatments:
Azithromycin